The Pain Pen for Breakthrough Cancer Pain

计划入组 50 人 · 首次发布于 2005 年 8 月 2 日

Characterisation and Epidemiology of Breakthrough Cancer Pain in Spain

计划入组 3,765 人 · 首次发布于 2016 年 9 月 14 日

Treatment of Breakthrough Cancer Pain According to European Guidelines

计划入组 131 人 · 首次发布于 2020 年 7 月 13 日

Fentanyl(Abstral, Actiq, Duragesic, Effentora, Fentora, Instanyl, Lazanda, Sublimaze, Subsys, PecFent)

C₂₂H₂₈N₂O · Rx

SRXXX (Cancer Pain)

pain therapeutic (pain)

PAIN THERAPEUTICS

United States

PINNACLE PAIN MEDICINE

United States

Kineta Chronic Pain LLC

United States

Nexalis Therapeutics Initiates Phase 2 Trial for IRX-211 in Breakthrough Cancer Pain

InhaleRx Secures Funding for Phase 2 Trials of IRX-211 in Breakthrough Cancer Pain

InhaleRx's IRX-211 Receives Approval for Phase II Breakthrough Cancer Pain Trial; Neurotech's NTI164 Shows Promise in PANDAS/PANS